Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Gufic Biosciences - Limited Review for the quarter ended Dec 31, 2006

 Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended December 31, 2006, the auditors of the Company have made the following observations:"The auditors are unable to express their opinion on the recoverability and consequently provision of the debts, aggregating to Rs 379.67 lacs, pertaining to debts outstanding for more than one year. However, in the opinion of the management, the same...
28-02-2007
Bigul

Gufic Biosciences - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

 The Exchange has received the following disclosure under Regulation 13 (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992: Name & Address of Director / Officer / Shareholders Gufic Biosciences - Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 199712:49The Exchange has received the following disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of Target company (Reporting company) ....31 Jan 2007Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 199716:02The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 199715:57The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....18 Dec 2006Gufic Biosciences - Limited Review for the quarter ended Sep 30, 200616:37Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended September 30, 2006, the auditors of the Company have made the following observations:"We are unable to express our opinion on the recoverability and consequently provision of Debts, aggregating to Rs 388.90 lacs, which continues to be outstanding for more than one year. However, in the opinion of the management, the same are good ....28 Sep 2006Gufic Biosciences - Outcome of AGM17:44Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:1. Adoption of the Audited...
01-02-2007
Bigul

Gufic Biosciences - Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

 The Exchange has received the following disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of Target company (Reporting company) ....31 Jan 2007Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 199716:02The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 199715:57The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....18 Dec 2006Gufic Biosciences - Limited Review for the quarter ended Sep 30, 200616:37Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended September 30, 2006, the auditors of the Company have made the following observations:"We are unable to express our opinion on the recoverability and consequently provision of Debts, aggregating to Rs 388.90 lacs, which continues to be outstanding for more than one year. However, in the opinion of the management, the same are good ....28 Sep 2006Gufic Biosciences - Outcome of AGM17:44Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet as at March 31, 2006, the Profit and Loss Account for the year ended as on that date and the Reports of the Board of Directors and the Auditors thereon. ....08 Sep 2006Gufic Biosciences - Outcome of...
01-02-2007
Bigul

Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997

 The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 199715:57The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....18 Dec 2006Gufic Biosciences - Limited Review for the quarter ended Sep 30, 200616:37Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended September 30, 2006, the auditors of the Company have made the following observations:"We are unable to express our opinion on the recoverability and consequently provision of Debts, aggregating to Rs 388.90 lacs, which continues to be outstanding for more than one year. However, in the opinion of the management, the same are good ....28 Sep 2006Gufic Biosciences - Outcome of AGM17:44Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet as at March 31, 2006, the Profit and Loss Account for the year ended as on that date and the Reports of the Board of Directors and the Auditors thereon. ....08 Sep 2006Gufic Biosciences - Outcome of Board Meeting15:11Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 04, 2006, inter alia, has taken the following decisions:1. Declare the dividend @ 16% p.a. subject to the...
31-01-2007
Bigul

Gufic Biosciences - Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997

 The Exchange has received the following disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: ....18 Dec 2006Gufic Biosciences - Limited Review for the quarter ended Sep 30, 200616:37Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended September 30, 2006, the auditors of the Company have made the following observations:"We are unable to express our opinion on the recoverability and consequently provision of Debts, aggregating to Rs 388.90 lacs, which continues to be outstanding for more than one year. However, in the opinion of the management, the same are good ....28 Sep 2006Gufic Biosciences - Outcome of AGM17:44Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet as at March 31, 2006, the Profit and Loss Account for the year ended as on that date and the Reports of the Board of Directors and the Auditors thereon. ....08 Sep 2006Gufic Biosciences - Outcome of Board Meeting15:11Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 04, 2006, inter alia, has taken the following decisions:1. Declare the dividend @ 16% p.a. subject to the approval of the members. 2. Approval of the draft notice of the Annual General Meeting, which will be held on September 28, 2006. Gufic Biosciences fixes Book Closure14:17Gufic Biosciences Ltd has...
31-01-2007
Bigul

Gufic Biosciences - Limited Review for the quarter ended Sep 30, 2006

 Gufic Biosciences Ltd has informed BSE that in the limited review report of the Company for the quarter ended September 30, 2006, the auditors of the Company have made the following observations:"We are unable to express our opinion on the recoverability and consequently provision of Debts, aggregating to Rs 388.90 lacs, which continues to be outstanding for more than one year. However, in the opinion of the management, the same are good...
18-12-2006
Bigul

Gufic Biosciences - Outcome of AGM

 Gufic Biosciences Ltd has informed BSE that the members at the 22nd Annual General Meeting (AGM) of the Company held on September 28, 2006, inter alia, have accorded to the following:1. Adoption of the Audited Balance Sheet as at March 31, 2006, the Profit and Loss Account for the year ended as on that date and the Reports of the Board of Directors and the Auditors thereon....
28-09-2006
Bigul

Gufic Biosciences - Outcome of Board Meeting

 Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 04, 2006, inter alia, has taken the following decisions:1. Declare the dividend @ 16% p.a. subject to the approval of the members. 2. Approval of the draft notice of the Annual General Meeting, which will be held on September 28, 2006.
08-09-2006
Bigul

Gufic Biosciences fixes Book Closure

 Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2006 to September 28, 2006 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting of the Company to be held on September 28, 2006.Further the Company has informed that the dividend on the Equity Shares of the Company proposed to be declared at the Annual General Meeting...
08-09-2006
Bigul

Gufic Biosciences - Board Meeting postponed

 Gufic Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company scheduled to be held on August 31, 2006 to consider the approval of Audited Financial Results of the Company, and recommendation of Dividend if any for the financial year ended March 31, 2006 has been postponed and same would be held on September 04, 2006.
31-08-2006
Next Page
Close

Let's Open Free Demat Account